Introduction
The obese patient presents a challenge for the spine surgeon. More than one-third of Americans have a body mass index (BMI) greater than 30, and current and future surgeons will be forced to address the issue.
1 Studies have shown that obese patients who undergo spine surgery have higher rates of perioperative and postoperative complications, such as urinary and pulmonary complications, extended length of stay, and more wound complications. [2] [3] [4] However, the obese
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Abstract
Study Design Observational study.
Objective Studies have shown a correlation between obesity and lumbar spine pathology, but also that obese patients have higher rates of complication following lumbar spine surgery. It is unknown if obese patients have clinical gains following lumbar spine surgery comparable to the gain of normal-weight patients. This study investigated the correlation of obesity and the delta change in outcomes in a single surgeon's cohort of normal-weight and obese patients undergoing minimally invasive (MIS) transforaminal lumbar interbody fusion (TLIF). population has nevertheless reported improvements in pain and functional outcomes on par with nonobese patients.
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The incidence of lumbar back pain, degenerative disk disease, and radiculopathy strongly correlate to obesity, and the prevalence of obesity is increasing, even at younger ages. 9, 10 Thus, the crux of the issue is to determine the true benefit of surgical intervention in the obese patient.
Transforaminal lumbar interbody fusion (TLIF) was developed to decompress the spine and achieve fusion. Historically, open TLIF has been an effective surgical technique with excellent clinical outcomes and fusion rates. 
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Complication rates in some studies were reduced in the MIS group compared with the open group. 18 However, it is not yet clear whether the obese patient experiences clinical benefits comparable to the nonobese patient. There is limited data addressing the comparison of patient-reported outcomes following only MIS TLIF in obese patients compared with nonobese patients. 19 The purpose of this study is to investigate the correlation of obesity and the change in outcomes in a single surgeon's cohort of normalweight and obese patients undergoing MIS TLIF.
Materials and Methods
A retrospective review was performed for patients of a single surgeon at an academic medical center who underwent MIS TLIF between July 2011 and December 2013. The electronic medical record and paper office charts were reviewed to retrieve data consistent with the study's inclusion criteria. This study was approved by the Institutional Review Board. All patients included in the study underwent an appropriate trial of nonoperative treatment including activity modification, physical therapy, anti-inflammatory medications, opioid analgesics, or transforaminal epidural steroid injections for at least 3 months. The operative indications included degenerative spondylosis or spondylolisthesis resulting in central or foraminal stenosis, radiculopathy, or neurogenic claudication, as well as failure of nonoperative management.
A standard MIS TLIF was performed in all cases. The patients were placed prone on a Jackson table with a chest roll was used to increase lumbar lordosis. Using fluoroscopic localization, the pedicles above and below the level of pathology were identified. A 2-to 3-cm incision was made lateral the pedicle on the side of the pathology. Jamshidi needles were then placed in the pedicles at the appropriate level. Guide wires were then advanced under fluoroscopic imaging. Following sequential dilation, a 21-mm tubular retractor was placed and docked on the pars interarticularis at the disk space. A laminectomy was performed on the ipsilateral side with removal of the medial edge of the pars, lamina, and the medial facet joint. To decompress the contralateral side, the tubular retractor was medicalized to allow undercutting of the spinous process. The facet joint was removed until the medial wall of the pedicle could be palpated. The ligamentum flavum was removed, the epidural veins overlying the disk space were coagulated, and the traversing nerve root was retracted medially. The disk space was then entered and prepared with the use of rongeurs, curettes, and disk space shavers. Trial interbody cages were inserted until appropriate tension was achieved. A combination of recombinant human bone morphogenetic protein-2 and local bone was placed anterior within the disk space followed by impaction of the final PEEK interbody cage. Percutaneous medical screws were then placed over the placed guide wires following appropriate tapping. Once all pedicle screws were placed, a rod was placed percutaneously and secured with end caps.
Epidemiologic variables were recorded, including age, sex, BMI, medical comorbidities, and smoking status. Prospectively recorded outcomes data included the 12-item Short-Form Health Survey-12 (SF-12). The mental composite score (MCS) and physical composite score (PCS) were calculated for both pre-and postoperative data.
GraphPad Prism v6.5 (La Jolla, California, United States) was utilized for statistical analysis with independent sample t test for continuous variables and Fisher exact test for categorical data. A repeated measures two-way analysis of variance (ANOVA) was used to assess the interaction between patient obesity status and the change in SF-12 outcomes scores from the preoperative to the postoperative state. A p value < 0.05 was considered statistically significant.
Results

Patient Characteristics and Demographics
The records of 38 patients from a single institution were reviewed. Patient characteristics can be found in ►Table 1. Obesity in the study was defined as a BMI > 30. Nineteen patients had a BMI < 30. Conversely, 19 patients had a BMI > 30. Of those with a BMI > 30, 11 patients were categorized as morbidly obese with a BMI > 35. The average age in the nonobese group was 60.00 AE 3.26 compared with 60. 26 
Obesity and Clinical Outcomes
The patients were divided into dichotomous groups (nonobese and obese), and average pre-and postoperative SF-12 
Discussion
Obesity remains a clinically relevant concern as the prevalence of obese and morbidly obese patients continues to rise. Current estimates identify roughly one-third of the U.S. population as obese. 20 These patients represent a significant challenge for the treating physician as a growing body of evidence supports a higher risk for perioperative complications including wound infections, airway-related events, deep vein thromboses, and even pulmonary embolus. 4, 5, [21] [22] [23] [24] [25] [26] Foley et al were the first to describe the MIS TLIF using tubular retractors via a muscle-splitting approach to decrease the amount of soft tissue injury. 27 The subsequent data has shown MIS TLIF to be safe and efficacious with clinical and radiographic results comparable to the open TLIF approach. The current study is one of the first to directly compare the change in outcomes between the preoperative and postoperative states of nonobese and obese patients undergoing MIS TLIF. To date, several studies have demonstrated the efficacy of MIS TLIF when compared with the open TLIF procedure in obese patients. Furthermore, evidence supports clinically significant gains in VAS, ODI, and SF-36 among obese patients undergoing MIS TLIF. However, there is limited published literature looking at the change in outcomes from the pre-to postoperative state between a nonobese and obese population that both underwent an MIS TLIF.
Rosen et al were the first to look at the role of obesity and patient-reported outcomes after MIS TLIF. 16 The authors looked at 110 patients, of whom 32% were defined as obese with a BMI > 30. Linear regression analysis did not identify a correlation between weight or BMI and pre-and postsurgery changes in any of the outcome measures. This study is limited in the conclusions that can be drawn due to a low number of patients included in both groups (seven nonobese, nine obese).
In the current study, the baseline SF-12 MCS and PCS were lower in the obese patient population, though the difference was only significant for the MCS. As the SF-12 is a general health survey, the lower preoperative score in the obese group is not surprising. In a study by Wee et al, obese patients when compared with normal-weight controls scored 8.8 points lower on the PCS-12 and 5.7 points lower on the PCS-36 after adjustment for age, sex, and race. 28 In the postoperative period, there were no significant differences between the nonobese and obese groups with respect to either SF-12 MCS or PCS. The net change from baseline for MCS was $7 points in the nonobese group and 15 points in the obese group. This change between pre-and postoperative scores was not significantly different between the two groups when analyzed with the two-way ANOVA model (p ¼ 0.33).
In the model, however, both groups demonstrated a statistically significant gain in MCS after surgery. Similarly, there was no significant difference between the average pre-and postoperative SF-12 PCS scores between the two groups. Although the obese group started at a lower baseline PCS state, each group improved by $15 points postoperatively. This change between pre-and postoperative scores was not significantly different between the two groups when analyzed with the two-way ANOVA (p ¼ 0.40). However, each group demonstrated a statistically significant improvement from their baseline state (p < 0.001).
The major limitations of this study are the retrospective nature and relatively small number of patients in each cohort. This study did not have a matched cohort; instead, it was a retrospective review of a single surgeon's consecutive series of patients. The outcomes data used in this study was prospectively collected by the treating surgeon as part of the normal scope of practice, which likely eliminates any bias in terms of data collection, as the data was systematically collected according to the surgeon's established postoperative protocol. Given the small number of patients in each arm of the study, it is possible that the study is underpowered to detect a true statistically significant difference in outcomes between the two groups. However, when compared with similar studies published in the literature, this study represents the largest cohort comparison of outcomes in nonobese and obese patients undergoing MIS TLIF.
Another potential limitation of this study is the use of only a single outcome metric for comparison between the two groups. It is possible that another validated outcome measure such as the Euroqol-5 Dimension, ODI, or VAS would have yielded a different result.
Conclusions
This study is one of the first and largest to look at the correlation of obesity and the change in outcomes between the preoperative and postoperative state in patients undergoing MIS TLIF. Patients undergoing MIS TLIF achieved meaningful and significant gains in SF-12 MCS and PCS that was not impacted by their obesity status.
